Correction of chronic granulomatous disease after second unrelated-donor umbilical cord blood transplantation

Pediatric Blood and Cancer

Volumn 49, Issue 7, 2007, Pages 982-984

  Parikh, Suhag H ^a   Szabolcs, Paul ^a   Prasad, Vinod K ^a   Lakshminarayanan, Sonali ^a   Martin, Paul L ^a   Driscoll, Timothy A ^a   Kurtzberg, Joanne ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aspergillosis; Chronic granulomatous disease; Graft failure; Granulocyte transfusions; Second transplants; Umbilical cord blood transplantation

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; AZATHIOPRINE; BUSULFAN; CASPOFUNGIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACLIZUMAB; FLUDARABINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VORICONAZOLE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CLINICAL FEATURE; CONVALESCENCE; FEVER; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; INFECTION; LOW DRUG DOSE; LUNG NODULE; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SWELLING; SYMPTOM; THORAX PAIN; UMBILICAL CORD BLOOD;

CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INFANT; MALE; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 35648989428     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21365     Document Type: Article

References (18)

1. Winkelstein J, Marino M, Johnston RJ, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000;79:155-169.
2. Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 2003;15:578-584.
3. Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: A survey of the European experience, 1985-2000. Blood 2002;100:4344-4350.
4. Del Giudice I, Iori A, Mengarelli A, et al. Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. Ann Hematol 2003;82:189-192.
5. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-166.
6. Bhattacharya A, Slatter M, Curtis A, et al. Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease. Bone Marrow Transplant 2003;31:403-405.
7. Suzuki N, Hatakeyama N, Yamamoto M, et al. Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation. Int J Hematol 2007;85:70-72.
8. Martin PL, Carter SL, Kernan NA, et al. Results of the Cord Blood Transplantation Study (COBLT): Outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 2006;12:184.
9. Ott MG, Schmidt M, Schwarzwaelder K, et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006;12:401-409.
10. Williams DA. Gene therapy advances but struggles to interpret safety data in small animal models. Mol Ther 2006;13:1027-1028.
11. Güngör T, Halter J, Klink A, et al. Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation 2005;79:1596-1606.
12. Sastry J, Kakakios A, Tugwell H, et al. Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection. Pediatr Blood Cancer 2006;47:327-329.
13. Schuetz C, Hoenig M, Schulz A, et al. Successful unrelated bone marrow transplantation in a child with chronic granulomatous disease complicated by pulmonary and cerebral granuloma formation. Eur J Pediatr 2007;166:785-788.
14. Szabolcs P, Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy 2007;9:111-122.
15. Horwitz ME, Barrett AJ, Brown MR, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft [see comment]. N Engl J Med 2001;344:881-888.
16. Morgenstern DE, Gifford MAC, Li LL, et al. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 1997;185:207-218.
17. Schelenz S, Smith D, Bancroft G. Cytokine and, chemokine responses following pulmonary challenge with Aspergillus fumigatus: Obligatory role of TNF-alpha and GM-CSF in neutrophil recruitment. Med Mycol 1999;37:183-194.
18. Fernandes J, Rocha V, Robin M, et al. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. Br J Haematol 2007;137:248-251.